Prelude Therapeutics gets $50M Series C funding
August 25, 2020
WILMINGTON – Prelude Therapeutics, a private life sciences start-up company, announced Aug. 24 that it has closed a $50 million Series C financing round, continuing its explosive growth in only […]
chat_bubble0 Comment
visibility2196 Views
Premier Digital Partners
© 2024 Delaware Business Times
